| MolName | [3,5-dihydroxy-6-oxo-8-[(2R,3R)-3,5,7-trihydroxy-3,4-dihydro-2H-chromen-2-yl]-1-(3,5,7-trihydroxy-3,4-dihydro-2H-chromen-2-yl)benzo[7]annulen-4-yl] 3,4,5-trihydroxybenzoate |
| MolecularFormula | C36H28O16 |
| Smiles | OC(C1)C(C(C(C2=C3O)=CC([C@H]([C@@H](C4)O)Oc5c4c(O)cc(O)c5)=CC3=O)=CC(O)=C2OC(c(cc2O)cc(O)c2O)=O)Oc2c1c(O)cc(O)c2 |
| InChI | InChI=1S/C36H28O16/c37-14-5-20(39)18-10-25(44)33(50-28(18)7-14)12-1-16-17(34-26(45)11-19-21(40)6-15(38)8-29(19)51-34)9-27(46)35(30(16)32(48)24(43)2-12)52-36(49)13-3-22(41)31(47)23(42)4-13/h1-9,25-26,33-34,37-42,44-47H,10-11H2,(H,43,48)/t25-,26?,33-,34?/m1 |
| InChIK | CKDOBTPKUHSESZ-MALJIYBWSA-N |
| TotalMolweight | 716.602 |
| Molweight | 716.602 |
| MonoisotopicMass | 716.13774 |
| CLogP | 1.9149 |
| CLogS | -3.851 |
| H Acceptors | 16 |
| H Donors | 11 |
| TotalSurfaceArea | 471.62 |
| Relative PSA | 0.42445 |
| PolarSurfaceArea | 284.36 |
| Druglikeness | 1.7767 |
| Mutagenic | low |
| Tumorigenic | none |
| Reproductive Effective | none |
| Irritant | none |
| Nasty Functions | |
| Shape Index | 0.34615 |
| Fragments | 1 |
| Non HAtoms | 52 |
| NonCHAtoms | 16 |
| Electronegative Atoms | 16 |
| StereoCenters | 4 |
| Rotatable Bond | 5 |
| Rings Closures | 7 |
| Small Rings | 7 |
| Aromatic Rings | 3 |
| Aromatic Atoms | 18 |
| Sp3Atoms | 20 |
| Symmetricatoms | 3 |
| StereoCon | unknown chirality |
Click to Load Molecule:
1 - [3,5-dihydroxy-6-oxo-8-[(2R,3R)-3,5,7-trihydroxy-3,4-dihydro-2H-chromen-2-yl]-1-(3,5,7-trihydroxy-3,4-dihydro-2H-chromen-2-yl)benzo[7]annulen-4-yl] 3,4,5-trihydroxybenzoate | 2 - [3,5-dihydroxy-6-oxo-8-[(2R,3R)-3,5,7-trihydroxy-3,4-dihydro-2H-chromen-2-yl]-1-(3,5,7-trihydroxy-3,4-dihydro-2H-chromen-2-yl)benzo[7]annulen-4-yl] 3,4,5-trihydroxybenzoate